FDA Approved: DOXEPIN HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental ANDA for doxepin hydrochloride from Mylan Pharmaceuticals Inc., enabling a generic version of the drug to enter the market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder
• Insomnia
• Major Depressive Disorder

Drugs mentioned

• DOXEPIN HYDROCHLORIDE (doxepin hydrochloride)

Snippet

SUPPL AP for DOXEPIN HYDROCHLORIDE (DOXEPIN HYDROCHLORIDE)